The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types Summary Neoadjuvant immunotherapy (NAIT), administering immunotherapy before surgery, is rapidly changing cancer treatment. Early trials show promising results, including higher rates of pathological complete response (Read More